(Q34312610)

1 August 2017

1 reference

title

Treatment with atypical antipsychotics: new indications and new populations (English)

1 reference

1 August 2017

I D Glick

1

1 reference

1 August 2017

S R Murray

2

1 reference

1 August 2017

P Vasudevan

3

1 reference

1 August 2017

S R Marder

4

1 reference

1 August 2017

R J Hu

5

1 reference

1 August 2017

publication date

1 May 2001

1 reference

Journal of Psychiatric Research

1 August 2017

published in

1 reference

1 August 2017

volume

35

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

187-191

1 reference

Publication bias and dissemination of clinical research.

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900020-6

Olanzapine compared to lithium in mania: a double-blind randomized controlled trial

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900020-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900020-6

inferred from DOI database lookup

7 January 2021

based on heuristic

A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900020-6

Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900020-6

Stuttering: neuropsychiatric features measured by content analysis of speech and the effect of risperidone on stuttering severity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900020-6

A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900020-6

Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900020-6

Risperidone as add-on therapy in behavioural disturbances in mental retardation: a double-blind placebo-controlled cross-over study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900020-6

Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900020-6

A double-blind pilot study of risperidone in the treatment of conduct disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900020-6

10.1016/S0022-3956(01)00020-6

7 January 2021

Identifiers

DOI

1 reference

1 August 2017

1 reference